Inflammatory signals from the tumor microenvironment, such as transforming growth factor-beta (TGF-β), promote the loss of E-cadherin, which normally keeps β-catenin retained at the plasma membrane, resulting in the accumulation of β-catenin in the cytoplasm and nucleus and allowing oncogenic transcription [126]. The gene discussed is TGFB1; the disease is neoplasm.